✦ LIBER ✦

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels

✍ Scribed by Sandra E. Ghayad; Ivan Bieche; Julie A. Vendrell; Celine Keime; Rosette Lidereau; Charles Dumontet; Pascale A. Cohen

Book ID: 108584334
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 621 KB
Volume: 99
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2008.00955.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altered Expression of Proliferation-Indu

Altered Expression of Proliferation-Inducing and Proliferation-Inhibiting Genes Might Contribute to Acquired Doxorubicin Resistance in Breast Cancer Cells

✍ Ekram M. Saleh; Raafat A. El-Awady; Mervat A. Abdel Alim; Abdel Hady A. Abdel Wa 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 540 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant